Latest other current liabilities for TNDM: $160M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Tandem Diabetes Care (TNDM) currently reports a other current liabilities of $160M as of June 2026. That compares with $170M in the prior-year period — down 3.2% year over year. Use the charts on this page to explore Tandem Diabetes Care's other current liabilities history and peer comparisons.
Tandem Diabetes Care's other current liabilities decreased from $170M to $160M — a 3.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Tandem Diabetes Care reported $160M in other current liabilities as of June 2026. That compares with $170M in the prior-year period — down 3.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current liabilities of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tandem Diabetes Care, and consider following TNDM for alerts when major investors trade the stock.
Tandem Diabetes Care is classified in the Healthcare sector. On other current liabilities, it currently shows $160M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TNDM with unrelated industries.